Michael Siekman > McDermott Will & Emery LLP > Boston, United States > Lawyer Profile

McDermott Will & Emery LLP has bolstered its broad life sciences team with a number of major lateral hires. Most notable in this is its expansion of the IP team, bringing new California-based practice co-head Douglas Carsten from Wilson Sonsini Goodrich & Rosati, expanding the firm’s litigation bench, which offers trial and arbitration services for patent disputes. Its transactional team has also continued to grow, with growing expertise in licensing and collaborations matters based out of the Chicago, Los Angeles and Atlanta offices. Another core element of the offering is regulatory work, with Washington DC-based co-head Vernessa Pollard advising on clinical research, marketing and post-market compliance. Also noteworthy are Boston-based IP experts Sarah Chapin Columbia and Michael Siekman, and Silicon Valley litigator William Gaede.

Operating from key innovation hubs, including Atlanta, Boston, Chicago, Silicon Valley, Los Angeles and Washington, DC, McDermott Will & Emery LLP‘s practice prepares and prosecutes patent applications and manages and protects the patent portfolios of clients such as Amgen, CRISPR Therapeutics, Facebook, and Shutterstock, showcasing its particular expertise in the life sciences and technology spaces. The prosecution group is headed by Chicago’s Ahsan Shaikh, while William Gaede in Silicon Valley acts as global head of the IP group. Other key attorneys include Boston’s Edward Gordon, who often takes the reins in negotiations in transactions involving IP assets as well as in negotiating joint ventures and strategic collaborations for global companies. Fellow Bostonian Michael Siekman‘s skills shine through in life sciences side of the practice. The later two are based in Boston.